In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab ...
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of ...
UCSF prepares for the May 14 AFSCME strike, maintaining essential patient care, emergency services, and operations with ...
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for ...
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right ...
Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to ...
Stay in touch with the latest updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results